Stephen Raffanti - Concepedia

Author

Stephen Raffanti

Also Known As

Golin, Carol, S P Raffanti, S Raffanti, S. P. Raffanti, S. Raffanti, STEPHEN RAFFANTI, Stephen P Raffanti, Stephen P. Raffanti, Stephen P. Raffanti,, Stephen Raffanti

Publications

2.5K

Citations

H-Index

103

Concepts

All Affiliations

Vanderbilt University Comprehensive Eye Care Vanderbilt University Medical Center Office of Infectious Diseases University of Miami

About

Stephen Raffanti is an author at Vanderbilt University specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	756
2	Public Health	7	7	181
3	Social Sciences	2	2	88
4	Natural Sciences	1	1	10
5	Nursing	1	1	29

Stephen Raffanti

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy Kassem Bourgi, Peter F. Rebeiro, Megan Turner, Clinical Infectious Diseases	2019	315
Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens Jamison Norwood, Megan Turner, Carmen Bofill, JAIDS Journal of Acquired Immune Deficiency Syndromes	2017	280
Race and Sex Differences in Antiretroviral Therapy Use and Mortality among HIV‐Infected Persons in Care Diana C. Lemly, Bryan E. Shepherd, Todd Hulgan, The Journal of Infectious Diseases	2009	114
Oxidant Stress Is Increased during Treatment of Human Immunodeficiency Virus Infection Todd Hulgan, Jason D. Morrow, Richard T. D’Aquila, Clinical Infectious Diseases InflammationAntiretroviral TherapyAtherosclerosisMedicineHuman Retrovirus	2003	113
CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy Jessica L. Castilho, Bryan E. Shepherd, John R. Koethe, AIDS	2015	111
Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity Marylyn D. Ritchie, David W. Haas, Alison A. Motsinger‐Reif, Clinical Infectious Diseases PharmacotherapyAntiviral DrugCase-control StudyViral HepatitisHepatotoxicity	2006	99
Pregnancy and HIV Disease Progression during the Era of Highly Active Antiretroviral Therapy Jennifer H. Tai, Mercy A. Udoji, Gema Barkanic, The Journal of Infectious Diseases	2007	81
Effect of Persistent Moderate Viremia on Disease Progression During HIV Therapy Stephen Raffanti, Jennifer S Fusco, Beth Sherrill, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	70
Absolute Count and Percentage of CD4<sup>+</sup>Lymphocytes Are Independent Predictors of Disease Progression in HIV‐Infected Persons Initiating Highly Active Antiretroviral Therapy Todd Hulgan, Bryan E. Shepherd, Stephen Raffanti, The Journal of Infectious Diseases	2007	68
Tropical spastic paraparesis‐like illness occurring in a patient dually infected with HIV‐1 and HTLV‐II Joseph Berger, Anders Svenningsson, Stephen Raffanti, Neurology Neuromusculoskeletal DisorderSpinal Cord InjuryClinical Infectious Disease34-Year-old ManHuman Retrovirus	1991	65

Page 1